Cargando…
The role of pemetrexed in recurrent epithelial ovarian cancer: A scoping review
Ovarian cancer is the leading cause of mortality among gynecologic malignancies, with most cases diagnosed at an advanced stage. Despite an initial response, most develop a recurrence and subsequent resistance to standard therapies. Pemetrexed (Alimta(TM)) is a new generation multi-targeted antifola...
Autores principales: | Roche, Michael, Parisi, Laura, Li, Linda, Knehans, Amy, Phaeton, Rebecca, Kesterson, Joshua P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007165/ https://www.ncbi.nlm.nih.gov/pubmed/29983902 http://dx.doi.org/10.4081/oncol.2018.346 |
Ejemplares similares
-
Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer
por: Jiang, Zewei, et al.
Publicado: (2019) -
Laparoscopy-Assisted Supracervical Hysterectomy for Ovarian Cancer: Cervical Recurrence
por: Fanning, James, et al.
Publicado: (2014) -
Tumor lysis syndrome in a patient with ovarian yolk sac tumor
por: VanHise, Katherine, et al.
Publicado: (2017) -
GPx3 supports ovarian cancer progression by manipulating the extracellular redox environment
por: Worley, Beth L., et al.
Publicado: (2018) -
Efficacy of Bevacizumab Combined with Pemetrexed in the Treatment of Recurrent and Metastatic Cervical Cancer
por: He, Ying, et al.
Publicado: (2022)